Gyre Therapeutics Inc (GYRE)

CapEx to Revenue

4.42%

Quarterly · Period ending:

GYRE logo

GYRE CapEx to Revenue

Latest reported4.42%
GYRE Quarterly CapEx/Revenue (39.09% → 4.42%)
High-resolution chart · PNG

GYRE capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.4185%
0.7904%
0.3871%
2.2347%
0.9383%
3.722%
2.6729%
2.7189%
5.7721%
0.8501%
8.5642%
6.1669%
8.449%
6.9873%
8.4591%
0%
0%
393.2437%
0%
21.4006%
30.6537%
0%
1.9202%
21.8365%
0.965%
0.1039%
0%
0%
0%
0%
-2,916.6667%
0%
0%
3,300%
6.2893%
0%
0%
1.107%
171.831%
20.1835%
215.5963%
81.6514%
89.9083%
159.633%
0%
0%
0.2402%
16%
0%
0%
0%
0%
0%
1.9796%
33.0508%
0.1302%
0.2705%
0.2013%
1.3302%
0.881%
1.9959%
1.5336%
6.8568%
0.9038%
1.5979%
5.9893%
1.4002%
0.2369%
1.0247%
1.5144%
1.6681%
-0.002%
-0.0027%
-0.0165%
84.3999%
0.0282%
0.0196%
24.4599%
0.5167%
0.0146%
103.226%
0.0316%
5.6315%
1.1797%
38.142%
39.0858%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.